HKE Holdings Limited (1726.HK)
HKD 1.69
(-2.31%)
HKD 1.69
(-2.31%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.12 Million | -14.83 Million | -9.48 Million | -618.76 Thousand | 2.29 Million | 897.57 Thousand |
| Net Income | -12.5 Million | -14.53 Million | -11.26 Million | 252.49 Thousand | 58.3 Thousand | 2.26 Million |
| Depreciation & Amortization | 1.01 Million | 946 Thousand | 866.6 Thousand | 165.4 Thousand | 194.63 Thousand | 101.58 Thousand |
| Deferred income taxes | - | 1.14 Million | -327.7 Thousand | - | - | - |
| Stock-based compensation | 618.85 Thousand | 547.5 Thousand | 387.68 Thousand | - | - | - |
| Change in working capital | -145.65 Thousand | -1.69 Million | -59.97 Thousand | -1.59 Million | 1.77 Million | -225.23 Thousand |
| Other non-cash items | -1.11 Million | -1.25 Million | 919.82 Thousand | 556.13 Thousand | 264.57 Thousand | -1.24 Million |
| Investing Cash Flow | 6.88 Million | -4.62 Million | -7.95 Million | -28.16 Thousand | 314.1 Thousand | 495.19 Thousand |
| Investments in PPE | -598.05 Thousand | -203.81 Thousand | -1.02 Million | -94.66 Thousand | -21.18 Thousand | -165.37 Thousand |
| Acquisitions | 711.98 Thousand | 4.62 Million | 1.00 | - | - | - |
| Investment purchases | - | -6.42 Million | -1.8 Million | - | - | - |
| Sales/Maturities of investments | 6.42 Million | 1.8 Million | 1.79 Million | - | - | - |
| Other Investing Activities | 347.47 Thousand | -4.41 Million | -6.93 Million | 66.5 Thousand | 335.28 Thousand | 660.57 Thousand |
| Financing Cash Flow | 8.19 Million | 15.31 Million | 10.61 Million | -65.37 Thousand | -93.58 Thousand | - |
| Debt repayment | - | -743.36 Thousand | -367.64 Thousand | -65.37 Thousand | -93.58 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 8.85 Million | 16.06 Million | 10.98 Million | - | - | - |
| Other Financing Activities | -660.53 Thousand | 15.31 Million | 10.61 Million | -65.37 Thousand | -93.58 Thousand | - |
| Accounts receivables | -22.33 Million | -1.69 Million | -59.97 Thousand | -1.59 Million | 1.77 Million | -225.23 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -70.21 Thousand | - | - | - |
| Other working capital | 22.19 Million | -345.31 Thousand | 70.21 Thousand | 88.66 Thousand | -190.41 Thousand | 1640.00 |
| Cash at beginning of period | 12.73 Million | 17.13 Million | 23.61 Million | 25.23 Million | 22.46 Million | 21.04 Million |
| Cash at end of period | 15.71 Million | 12.73 Million | 17.13 Million | 23.61 Million | 25.23 Million | 22.46 Million |
| Capital Expenditure | -598.05 Thousand | -203.81 Thousand | -1.02 Million | -94.66 Thousand | -21.18 Thousand | -165.37 Thousand |
| Effect of forex changes on cash | 29.02 Thousand | -260.38 Thousand | 332.11 Thousand | -910.97 Thousand | 254.66 Thousand | 28.94 Thousand |
| Net cash flow / Change in cash | 2.98 Million | -4.4 Million | -6.48 Million | -1.62 Million | 2.77 Million | 1.42 Million |
| Free Cash Flow | -12.72 Million | -15.04 Million | -10.5 Million | -713.42 Thousand | 2.27 Million | 732.19 Thousand |
| Breakdown | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 | 2021 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.83 Million | -6.81 Million | -14.53 Million | -7.12 Million | -7.41 Million | -9.48 Million |
| Depreciation & Amortization | - | 469.44 Thousand | 946 Thousand | 447.64 Thousand | 498.36 Thousand | 596.91 Thousand |
| Deferred income taxes | - | - | 1.14 Million | -376.16 Thousand | 761.37 Thousand | 71.64 Thousand |
| Stock-based compensation | -363.92 Thousand | 363.92 Thousand | 547.5 Thousand | 265.98 Thousand | 281.52 Thousand | 305.89 Thousand |
| Change in working capital | - | -1.19 Million | -1.69 Million | -371.52 Thousand | -1.66 Million | -503.16 Thousand |
| Other non-cash items | 6.2 Million | 1.54 Million | -1.25 Million | -558.12 Thousand | 799.71 Thousand | 250.9 Thousand |
| Investing Cash Flow | - | 5.04 Million | -4.62 Million | -5.85 Million | 1.23 Million | 5.68 Million |
| Investments in PPE | - | -278.21 Thousand | -203.81 Thousand | -112.96 Thousand | -90.84 Thousand | -294.11 Thousand |
| Acquisitions | - | 62 Thousand | 4.62 Million | - | - | - |
| Investment purchases | - | - | -6.42 Million | - | - | - |
| Sales/Maturities of investments | - | - | 1.8 Million | - | - | - |
| Other Investing Activities | - | 5.26 Million | -4.41 Million | -5.74 Million | 1.32 Million | 5.97 Million |
| Financing Cash Flow | - | -305.87 Thousand | 15.31 Million | 15.69 Million | -376.27 Thousand | -186.83 Thousand |
| Debt repayment | - | -305.87 Thousand | -743.36 Thousand | - | -376.27 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 16.06 Million | - | - | - |
| Other Financing Activities | - | - | 15.31 Million | 15.69 Million | -376.27 Thousand | -186.83 Thousand |
| Accounts receivables | - | -643.83 Thousand | -1.69 Million | 110.17 Thousand | -1.8 Million | -449.18 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | -548.53 Thousand | -345.31 Thousand | -481.69 Thousand | 136.38 Thousand | -53.98 Thousand |
| Cash at beginning of period | 11.7 Million | 12.73 Million | 17.13 Million | 10.27 Million | 17.13 Million | 20.23 Million |
| Cash at end of period | 11.7 Million | 11.7 Million | 12.73 Million | -140.76 Thousand | 10.27 Million | -1.55 Million |
| Capital Expenditure | - | -278.21 Thousand | -203.81 Thousand | -112.96 Thousand | -90.84 Thousand | -294.11 Thousand |
| Effect of forex changes on cash | - | -139.22 Thousand | -260.38 Thousand | -44.76 Thousand | -215.62 Thousand | 240.03 Thousand |
| Net cash flow / Change in cash | - | -1.02 Million | -4.4 Million | -10.41 Million | -6.85 Million | -21.78 Million |
| Free Cash Flow | - | -5.9 Million | -15.04 Million | -7.45 Million | -7.58 Million | -9.13 Million |
CJCFF
NANX
4207
MSV
000826
1569